Literature DB >> 20103614

Elevated hepatic enzymes potentially associated with sitagliptin.

Benjamin N Gross, L Brian Cross, Joni Foard, Yelena Wood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103614     DOI: 10.1345/aph.1M323

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  4 in total

1.  Acute Liver Injury Induced by Sitagliptin: Report of Two Cases and Review of Literature.

Authors:  Amir Shahbaz; Kashif Aziz; Muhammad Umair; Mohaddeseh Sharifzadeh; Issac Sachmechi
Journal:  Cureus       Date:  2018-06-11

2.  Antidiabetic Drug Sitagliptin with Divalent Transition Metals Manganese and Cobalt: Synthesis, Structure, Characterization Antibacterial and Antioxidative Effects in Liver Tissues.

Authors:  Samy M El-Megharbel; Najah M Al-Baqami; Eman H Al-Thubaiti; Safa H Qahl; Bander Albogami; Reham Z Hamza
Journal:  Curr Issues Mol Biol       Date:  2022-04-20       Impact factor: 2.976

Review 3.  Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2014-09       Impact factor: 6.447

4.  Sitagliptin-Dependent Differences in the Intensity of Oxidative Stress in Rat Livers Subjected to Ischemia and Reperfusion.

Authors:  Małgorzata Trocha; Małgorzata Krzystek-Korpacka; Anna Merwid-Ląd; Beata Nowak; Małgorzata Pieśniewska; Piotr Dzięgiel; Agnieszka Gomułkiewicz; Przemysław Kowalski; Dorota Diakowska; Adam Szeląg; Tomasz Sozański
Journal:  Oxid Med Cell Longev       Date:  2019-10-31       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.